bioAffinity Technologies, Inc. (NASDAQ:BIAFW – Get Free Report) was the recipient of a large decline in short interest during the month of July. As of July 15th, there was short interest totaling 691 shares, a decline of 39.1% from the June 30th total of 1,134 shares. Based on an average trading volume of 614 shares, the days-to-cover ratio is currently 1.1 days.
bioAffinity Technologies Stock Performance
Shares of NASDAQ:BIAFW remained flat at $0.09 during trading on Friday. bioAffinity Technologies has a 12 month low of $0.05 and a 12 month high of $0.81. The firm has a 50-day moving average price of $0.14 and a 200 day moving average price of $0.24.
About bioAffinity Technologies
bioAffinity Technologies, Inc is a clinical-stage medical device company developing an extracorporeal immunoadsorption platform intended to treat Gram-negative sepsis and other severe inflammatory conditions. The company’s technology employs specialized sorbent cartridges designed to selectively bind and remove circulating endotoxins and inflammatory mediators from the bloodstream, with the goal of supporting critical care interventions and improving patient outcomes.
In preclinical studies, bioAffinity’s hemoperfusion devices have demonstrated the ability to capture lipopolysaccharides released by Gram-negative bacteria, leading to reductions in pro-inflammatory cytokines and enhanced survival rates in animal models.
Featured Stories
- Five stocks we like better than bioAffinity Technologies
- Amazon’s Earnings Beat Shows Why AWS Is Back at the Center of the Bull Case
- Apple’s Record Quarter Could Not Outrun Its Guidance Problem
- McKesson’s Compounding Keeps Adding Up
- Peeling Out or Breaking Down? Ford’s High-Stakes Turnaround
Receive News & Ratings for bioAffinity Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for bioAffinity Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
